Karyopharm Therapeutics: Q1 Earnings Snapshot
By Ap News
Published - May 08, 2024, 07:42 AM ET
Last Updated - May 27, 2024, 01:00 AM EDT
NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Wednesday reported a loss of $37.4 million in its first quarter.
On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 32 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.
The pharmaceutical company posted revenue of $33.1 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $35 million.
